91 related articles for article (PubMed ID: 16461008)
1. Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors.
Lim MJ; Min SH; Lee JJ; Kim IC; Kim JT; Lee DC; Kim NS; Jeong S; Kim MN; Kim KD; Lim JS; Han SB; Kim HM; Heo DS; Yeom YI
Mol Ther; 2006 May; 13(5):899-909. PubMed ID: 16461008
[TBL] [Abstract][Full Text] [Related]
2. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.
Tsukuda K; Wiewrodt R; Molnar-Kimber K; Jovanovic VP; Amin KM
Cancer Res; 2002 Jun; 62(12):3438-47. PubMed ID: 12067986
[TBL] [Abstract][Full Text] [Related]
3. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.
McCabe MT; Low JA; Imperiale MJ; Day ML
Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506
[TBL] [Abstract][Full Text] [Related]
4. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.
Levine AJ
Virology; 2009 Feb; 384(2):285-93. PubMed ID: 19081592
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy targeting for carcinoma regulated by E2F-1 promoter].
Zhang XW; Meng ZH; Zhao JS; Zhang D; Xie YJ; Gao SH; Wang CY
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1636-9. PubMed ID: 17359698
[TBL] [Abstract][Full Text] [Related]
7. Differential binding of the transcription factors Sp1, AP-1, and NFI to the promoter of the human alpha5 integrin gene dictates its transcriptional activity.
Gingras ME; Masson-Gadais B; Zaniolo K; Leclerc S; Drouin R; Germain L; Guérin SL
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):57-67. PubMed ID: 18775869
[TBL] [Abstract][Full Text] [Related]
8. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
9. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
[TBL] [Abstract][Full Text] [Related]
10. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
11. CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors.
Gaussin A; Modlich U; Bauche C; Niederländer NJ; Schambach A; Duros C; Artus A; Baum C; Cohen-Haguenauer O; Mermod N
Gene Ther; 2012 Jan; 19(1):15-24. PubMed ID: 21562592
[TBL] [Abstract][Full Text] [Related]
12. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.
Roh V; Laemmle A; Von Holzen U; Stroka D; Dufour JF; Hunt KK; Candinas D; Vorburger SA
Cancer Gene Ther; 2008 Oct; 15(10):636-44. PubMed ID: 18535617
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
14. [On the role of liver-enriched transcription factors in regulating HBV transcription and replication].
Wang S; Tang H; He F; Liu L; Huang FJ; Zhou TY; Zhao LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):35-9. PubMed ID: 16468637
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
16. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
Araki K; Kawauchi K; Tanaka N
Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.
Sabbioni S; Callegari E; Spizzo R; Veronese A; Altavilla G; Corallini A; Negrini M
Cancer Gene Ther; 2007 Mar; 14(3):297-305. PubMed ID: 17218949
[TBL] [Abstract][Full Text] [Related]
19. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
Zhang HJ; Li WJ; Yang SY; Li SY; Ni JH; Jia HT
J Cell Biochem; 2009 Feb; 106(3):464-72. PubMed ID: 19115249
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
